Gottlieb Recognizes OTC Monograph Woes During Confirmation Hearing

FDA commissioner nominee Scott Gottlieb agreed that the OTC drug monographs constitute “a system that is in need of modernization” during his April 5 confirmation hearing before the Senate HELP Committee. HELP Democrats tested the FDA commissioner nominee’s willingness to “stand up to the administration” and probed potential conflicts of interest.

FDA Commissioner nominee Scott Gottlieb says the OTC monograph program, a system the agency is looking at modernizing, needed “immediate action” 10 years ago before he left a commissioner’s office post.

Gottlieb was asked only one question about nonprescription drugs regulation during his confirmation hearing before the Senate Health, Education, Labor and Pensions Committee on April 5, but it covered

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation